A new debut on AIM Italia: BioDue

May 20 2015 - 11:00

-       The company produces and commercialises medical devices, dermo-cosmetic products and nutrition supplements

-       €4 million raised at IPO

Today Borsa Italiana welcomes BioDue on AIM Italia, the market dedicated to small and medium enterprises. BioDue is a company from Tuscany which produces and commercialises medical devices, dermo-cosmetic products and nutrition supplements.

BioDue raised €4 million at IPO. At the moment of admission the free-float is 10,1% with a market capitalisation of about €40 million. Baldi & Partners S.r.l. acts as Nomad of the operation.

After the admission of BioDue AIM Italia includes 66 companies with a capitalisation of more than €2 billion.

Barbara Lunghi, Head of the market of Borsa Italiana dedicated to SMEs, commented: 

“AIM Italia is confirming its role as one of the most attractive financial tools for small and medium enterprises that are willing to grow. We are confident that thanks to its listing on AIM Italia BioDue will be able to raise capital and realise its plans of development”.

Tomorrow BioDue will become a constituent of FTSE AIM Italia.

For further information, please contact:
Media Relations
Oriana Pagano
Sofia Crosta
+39 0272426 360

To download the Pdf: VIEW PDF pdf

The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.